Fig. 4

A schematic overview of strategies developed for inducible CAR receptor degradation. CARs with incorporated degradation domains might be degraded or protected against degradation by a small molecule drug. In other technologies, a CAR-inhibiting protein is co-expressed with CAR to regulate CAR function based on the presence or absence of a small molecule